- Home
- PBYI vs EVF Comparison
PBYI vs EVF Comparison
Compare PBYI & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- EVF
- Stock Information
- Founded
- PBYI 2010
- EVF 1998
- Country
- PBYI United States
- EVF United States
- Employees
- PBYI N/A
- EVF N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- EVF Investment Managers
- Sector
- PBYI Health Care
- EVF Finance
- Exchange
- PBYI Nasdaq
- EVF Nasdaq
- Market Cap
- PBYI 126.5M
- EVF 110.2M
- IPO Year
- PBYI N/A
- EVF N/A
- Fundamental
- Price
- PBYI $2.65
- EVF $6.22
- Analyst Decision
- PBYI Strong Buy
- EVF
- Analyst Count
- PBYI 1
- EVF 0
- Target Price
- PBYI $7.00
- EVF N/A
- AVG Volume (30 Days)
- PBYI 303.9K
- EVF 93.3K
- Earning Date
- PBYI 10-31-2024
- EVF 01-01-0001
- Dividend Yield
- PBYI N/A
- EVF 10.68%
- EPS Growth
- PBYI N/A
- EVF N/A
- EPS
- PBYI 0.18
- EVF 0.94
- Revenue
- PBYI $219,143,000.00
- EVF N/A
- Revenue This Year
- PBYI N/A
- EVF N/A
- Revenue Next Year
- PBYI N/A
- EVF N/A
- P/E Ratio
- PBYI $14.56
- EVF $6.74
- Revenue Growth
- PBYI N/A
- EVF N/A
- 52 Week Low
- PBYI $2.13
- EVF $5.20
- 52 Week High
- PBYI $7.73
- EVF $6.84
- Technical
- Relative Strength Index (RSI)
- PBYI 52.38
- EVF 53.27
- Support Level
- PBYI $2.41
- EVF $6.16
- Resistance Level
- PBYI $2.69
- EVF $6.23
- Average True Range (ATR)
- PBYI 0.14
- EVF 0.05
- MACD
- PBYI 0.03
- EVF 0.01
- Stochastic Oscillator
- PBYI 85.71
- EVF 84.67
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.